INNOMED INNOVATION MEDICAL ApS: Financial statements 2023
CVR: 25139356
INNOMED INNOVATION MEDICAL ApS (CVR 25139356) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 305,255 and a net result of DKK 97,212 compared with DKK -41,296 the year before. That is an increase of 69.8% compared with the year before. Equity amounted to DKK 278,393. The solvency ratio was 22.9%. The company had 3 employees in the financial year.
- Gross Profit
- 305,255 kr.
- Profit/Loss
- 97,212 kr.
- Equity
- 278,393 kr.
- Total Assets
- 1,214,375 kr.
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 305 t. | 97 t. | 278 t. | 3 |
| 2022 | - | 180 t. | -41 t. | 181 t. | 2 |
| 2021 | - | 240 t. | 4 t. | 222 t. | 2 |
| 2020 | - | 420 t. | 158 t. | 218 t. | 2 |
| 2019 | - | 474 t. | 196 t. | 520 t. | 3 |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
INNOMED INNOVATION MEDICAL ApS has published its annual report for 2022. Gross profit came to DKK 179,774, and the net result was DKK -41,296.
About INNOMED INNOVATION MEDICAL ApS
INNOMED INNOVATION MEDICAL ApS is a Danish company of the type Anpartsselskab based in Hirtshals, founded in 1999. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Jens Kjeldgaard. The company is owned by Jens Kjeldgaard. The company has 3 employees. In 2025, the company reported a gross profit of DKK 248,225 and a net result of DKK 41,979 compared with DKK 64,825 the year before. Equity amounted to DKK 385,198.
